(12) United States Patent (10) Patent No.: US 8,029,992 B2 Rapko Et Al
Total Page:16
File Type:pdf, Size:1020Kb
USO08029992B2 (12) United States Patent (10) Patent No.: US 8,029,992 B2 Rapko et al. (45) Date of Patent: Oct. 4, 2011 (54) METHODS OF EVALUATING CELLS AND guishes chondrocytes from Synovial cells. Tissue Engineering. Part CELL CULTURES C. Methods, vol. 16, No. 6, pp. 1367-1375, Dec. 2010.* Appendix A of Real-Time PCR Systems: Applied Biosystems (75) Inventors: Stephen M. Rapko, Franklin, MA (US); 7900HT Fast Real-Time PCR System and 7300/7500 Real-Time Stephen J. Duguay, Salem, MA (US) PCR Systems, Chemistry Guide, Applied Biosystems, 2005, Part No. 4348358 Rev. E. pp. A1-A4. Applied Biosystems, "Amplification Efficiency of TaqMan(R) Gene (73) Assignee: Genzyme Corporation, Cambridge, MA Expression Assays”. Application Note TaqMan(R) Gene Expression (US) Assays, Publication 127AP05-03 (2006), printed as pp. 1-6. Applied Biosystems, Taq Man R Gene Expression Assays, ASSay ID (*) Notice: Subject to any disclaimer, the term of this Hs00157103 ml, retrieved online at https://products.ap patent is extended or adjusted under 35 pliedbiosystems.com on Oct. 30, 2006, printed as pp. 1-3. U.S.C. 154(b) by 559 days. Applied Biosystems, Taq Man R Gene Expression Assays, ASSay ID Hs00185803 ml, retrieved online at https://products.ap (21) Appl. No.: 12/098,033 pliedbiosystems.com on Oct. 30, 2006, printed as pp. 1-3. Basad, et al. Treatment of Chondral Defects by Matrix-Guided (22) Filed: Apr. 4, 2008 Autologous Chondrocyte Implantation (MACI), in Cartilage Sur gery and Future Perspectives 50-56 (2003). (65) Prior Publication Data Benya, et al., “Dedifferentiated Chondrocytes Rexpress the Differ entiated Collagen Phenotype When Cultured in Agarose Gels”. Cell, US 2008/02484.81 A1 Oct. 9, 2008 30:215-224 (1982). Binette, et al., “Expression of a Stable Articular Cartilage Phenotype Related U.S. Application Data without Evidence of Hypertrophy by Adult Human Articular Chondrocytes. In Vitro”, Jour: of Orthopaed Research., 16:207-216 (60) Provisional application No. 60/910,574, filed on Apr. (1998). 6, 2007. Brittberg et al., “Treatment of Deep Cartilage Defects in the Knee with Autologous ChondrocyteTransplantation'. N.E.J. of Medicine, (51) Int. Cl. 331;889-895 (1994). CI2O I/68 (2006.01) Brittberg, M., “Autologous Chondrocyte Transplantation'. Clin. CI2O 1/02 (2006.01) Orthopaedics and Related Research, 367S:S147-155 (1999). CI2P 19/34 (2006.01) Buckwalter, et al., “The Effect of Link Protein on Proteoglycan GOIN33/53 (2006.01) Aggregate Structure'. Jour: of Biological Chem., 259(9):5361-5363 (1984). (52) U.S. Cl. ............... 435/6: 435/29: 435/91.2: 435/7.1 Cherubino, et al., “Autologous chondrocyte implantation using a (58) Field of Classification Search ........................ None bilayer collagen membrane: A preliminary report. Jour: of See application file for complete search history. Orthopaedic Surgery, 11(1):10-15 (2003). Galbraith, et al., “Global analysis of cell type-specific gene expres (56) References Cited sion'. Comparative and Functional Genomics, 4:208-215 (2003). U.S. PATENT DOCUMENTS (Continued) 6,150,163 A 11/2000 McPherson et al. 7,169,610 B2 1/2007 Brown 2003/0087259 A1* 5/2003 Clancy et al. ..................... 435/6 Primary Examiner — Jennifer Dunston 2007/0292949 A1 12/2007 Duguay (74) Attorney, Agent, or Firm — Finnegan, Henderson, Farabow, Garrett & Dunner, LLP FOREIGN PATENT DOCUMENTS WO WO 2006/094836 A2 9, 2006 WO WO 2007 149328 12/2007 (57) ABSTRACT OTHER PUBLICATIONS Methods of evaluating the composition of a cell culture (e.g., Pusztai and Hess. Clinical trial design for microarray predictive to distinguish chondrocytes from fibroblasts) and methods for marker discovery and assessment. Annals of Oncology, vol. 15, pp. evaluating the phenotype of an individual cell (e.g., as a 1731-1737, 2004.* chondrocyte) are disclosed. The methods may be used, for Golub et al. Molecular classification of cancer: Class discovery and example, for assessing chondrocyte cultures used for treat class prediction by gene expression monitoring. Science, vol. 286, ment of cartilage defects. In some embodiments, the inven pp. 531-537, Oct. 1999.* tion involves identifying cell culture composition or the iden Tan et al. Classification analysis of the transcriptosome of tity of a cell based on expression level of a fibroblast marker. nonlesional cultured dermal fibroblasts from systemic sclerosis In other embodiments, the invention involves comparing patients with early disease. Arthitis & Rhematism, vol. 52, No. 3, pp. expression levels of at least one chondrocyte marker and at 865-876, Mar. 2005.* Entrez Gene entry for MFAP5 microfibrillar associated protein 5 least one fibroblast marker in a cell culture sample or in an Homo sapiens). Gene ID: 8076, updated on Nov. 1, 2010, printed as individual cell. In illustrative embodiments, the chondrocyte pp. 1-5 on Nov. 9, 2010.* marker is hyaluronan and proteoglycan link protein 1 Entrez Gene entry for HAPLN1 hyaluronan and proteoglycan link (HAPLN1), and the fibroblast marker is microfibrillar asso protein 1 Homo sapiens. Gene ID: 1404, updated on Nov. 1, 2010, ciated protein 5 (MFAP5). printed as pp. 1-6 on Nov. 9, 2010.* Rapko et al. Identification of the chondrocyte lineage using microfibril-associated glycoprotein-2, a novel marker that distin 34 Claims, 18 Drawing Sheets US 8,029.992 B2 Page 2 OTHER PUBLICATIONS Gibson, et al., “Microfibril-associated Glycoprotein-2 (MAGP-2) Is GenBank Accession No. NM 000095, “Homo sapiens cartilage Specifically Associated with Fibrillin-containing Microfibrils but Exhibits More Restricted Patterns of Tissue Localization and Devel oliomeric matrix protein (COMP), mRNA'. Dec. 2003. opmental Expression Than Its Structural Relative MAGP-1”,Jour: of GenBank Accession No. NM 000346, "Homo sapiens SRY (Sex Histochem. & Cytochem., 46(8):871-885 (1998). determining region Y)-box 9 (campomelic dysplasia, autosomal sex Haudenschild, et al., “Differential Expression of Multiple Genes reversal) (SOX9), mRNA'. Jul. 2005. During Articular Chondrocyte Redifferentiation'. The Anatomical GenBank Accession No. NM 000900, “Homo sapiens matrix Gla Record, 263:91-98 (2001). protein (MGP), mRNA'. Feb. 2006. Imabayashi, et al., “Redifferentiation of dedifferentiated GenBank Accession No. NM 00101 1705, "Homo sapiens chondrocytes and chondrogenesis of human bone marrow Stromal leukocyte cell derived chemotaxin 1 (LECT1), transcript variant 2, cells via chondrosphereformation with expression profiling by large mRNA'. Aug. 2006. scale cDNA analysis”. Experimental Cell Research, 288:35-50 GenBank Accession No. NM 001135, "Homo sapiens aggrecan 1, (2003). transcript variant 1, mRNA'. Oct. 2004. Lemaire, et al., “Increased Expression of Type I Collagen Induced by GenBank Accession No. NM 001844. "Homo sapiens collagen, Microfibril-Associated Glycoprotein 2'. Arthritis & Rheumatism, type II, alpha I (COL2A1), transcript variant 1, mRNA'. Apr. 2003. 52: 1812-1823 (2005). GenBank Accession No. NM 001851, “Homo sapiens collagen, Lemaire, et al., “Mutant Fibrillin 1 From tight Skin Mice Increases type IX, alpha 1 (COL9A1), transcript variant 1, mRNA'. Oct. 2006. Extracellular Matrix Incorporation of Microfibril-Associated GenBank Accession No. NM 001854, "Homo sapiens collagen, Glycoprotein 2 and type I Collagen'. Arthritis & Rheumatism, type XI, alpha 1 (COL11A1), transcript variant A, mRNA'. Sep. 50(3):915-926 (2004). 2006. Leung, et al., “Fundametnals of cDNA microarray data analysis'. GenBank Accession No. NM 001884. "Homo sapiens hyaluronan TRENDS in Genetics, 19(11):649-659 (2003). and proteoglycan link protein 1 (HAPLN1)”, Oct. 2005. Linsenmeyer et al., “Monoclonal Antibodies to Connective Tissue GenBank Accession No. NM 003880, “Homo sapiens WNT1 Macromolecules: Type II Collagen'. Biochem. Biophys. Res. Com., inducible signaling pathway protein 3 (WISP3), transcript variant 1, 92(2):440-6 (1980). mRNA'. Aug. 2006. Marlovits, et al., “Early postoperative adherence of matrix-induced GenBank Accession No. NM 005711. "Homo sapiens EGF-like autologous chondrocyte implantation for the treatment of full-thick repeats and discoidin I-like domains 3 (EDIL3), mRNA'. Oct. 2005. ness cartilage defects of the femoral condyle'. Knee Surg. Sports GenBank Accession No. NM 006272, "Homo sapiens S100 cal Traumatol Arthrosc. 12:451-457 (2005). cium binding protein, beta (neural) (S100B), mRN”. Aug. 2005. Rapko, et al., “DNA Methylation Analysis as Novel Tool for Quality GenBank Accession No. NM 006393, "Homo sapiens nebulette Control in Regenerative Medicine”. Tissue Engineering, 13(9):2271 (NEBL), transcript variant 1 mRNA'. Apr. 2008. 2280 (2007). GenBank Accession No. NM 007015, "Homo sapiens leukocyte Reno et al., “Rapid Isolation of Total RNA from Small Samples of cell derived chemotaxin 1 (LECT1), transcript variant 1, mRNA'. Hypocellular, Dense Connective Tissues'. Biotechniques, Apr. 2005. 22(6):1082-1086 (1997). GenBank Accession No. NM 013227. “Homo sapiens aggrecan 1 International Search Report issued in PCT/US2008/059275, mailed (AGC1), transcript variant 2, mRNA'. Oct. 2004. on Aug. 5, 2008. GenBank Accession No. NM 018058, “Homo sapiens cartilage Written Opinion issued in PCT/US2008/059275, mailed on Aug. 5, acidic protein 1 (CRTAC1), mRNA'. Sep. 2005. 2008. GenBank Accession No. NM 033150, “Homo sapiens collagen, Kolettas, E. et al. “Expression of cartilage-specific molecules is type II, alpha 1 (COL2A1), transcript variant 2, mRNA'. Apr. 2003. retained on long-term culture of human articular chondrocytes' J. GenBank Accession No. NM 078485. “Homo sapiens collagen,